Washington, September 28, 2026: The U.S. Food and Drug Administration has approved Onswik (insulin efsitora alfa-gobe), a once-weekly insulin treatment for type 2 diabetes.
Weekly treatment
The FDA listed the approval on September 23. The treatment is designed for adults with type 2 diabetes and offers a weekly dosing option rather than daily basal insulin.
Medical supervision required
People with diabetes should consult their healthcare professionals before changing insulin treatment. Dosing and safety depend on individual medical circumstances.
Source: FDA
Never miss a storyFollow News Nation Online on WhatsApp for breaking news from India and the world.
Internal: Health & Fitness | Science & Space
जालना, महाराष्ट्र और देश-दुनिया की ताज़ा खबरें
सीधे अपनी Facebook फ़ीड में पाएँ — News Nation Online पेज को Follow करें।
👍 Facebook पर Follow करेंसीधे अपनी Facebook फ़ीड में पाएँ — News Nation Online पेज को Follow करें।
Discover more from NewsNation Online
Subscribe to get the latest posts sent to your email.
आपके लिए सुझाव
